- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 141585, 7 pages
Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC
1Dipartimento di Chirurgia Pietro Valdoni, Azienda Policlinico Umberto I, Università degli Studi di Roma “La Sapienza,” 00161 Roma, Italy
2Dipartimento di Medicina Sperimentale, Azienda Policlinico Umberto I, Università degli Studi di Roma “La Sapienza,” 00161 Roma, Italy
Received 26 January 2012; Accepted 17 February 2012
Academic Editor: Paul H. Sugarbaker
Copyright © 2012 Paolo Sammartino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [20 citations]
The following is the list of published articles that have cited the current article.
- Joshua Winer, Mazen Zenati, Lekshmi Ramalingam, Heather Jones, Amer Zureikat, Matthew Holtzman, Kenneth Lee, Steven Ahrendt, James Pingpank, Herbert J. Zeh, David L. Bartlett, and Haroon A. Choudry, “Impact of Aggressive Histology and Location of Primary Tumor on the Efficacy of Surgical Therapy for Peritoneal Carcinomatosis of Colorectal Origin,” Annals of Surgical Oncology, vol. 21, no. 5, pp. 1456–1462, 2013.
- P. Sammartino, S. Sibio, D. Biacchi, M. Cardi, P. Mingazzini, M. S. Rosati, T. Cornali, B. Sollazzo, J. Maherfouad Atta, and A. Di Giorgio, “Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases,” International Journal of Colorectal Disease, vol. 29, no. 9, pp. 1081–1089, 2014.
- Vladimir G. Budker, Sean D. Monahan, and Vladimir M. Subbotin, “Loco-regional cancer drug therapy: Present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction,” Drug Discovery Today, 2014.
- Y.R.B.M. van Gestel, I. Thomassen, V.E.P.P. Lemmens, J.F.M. Pruijt, M.P.P. van Herk-Sukel, H.J.T. Rutten, G.J. Creemers, and I.H.J.T. de Hingh, “Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer,” European Journal of Surgical Oncology (EJSO), vol. 40, no. 8, pp. 963–969, 2014.
- D.A.M. Sloothaak, T.J. Gardenbroek, J. Crezee, W.A. Bemelman, C.J.A. Punt, C.J. Buskens, and P.J. Tanis, “Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis,” European Journal of Surgical Oncology (EJSO), 2014.
- D A M Sloothaak, B Mirck, C J A Punt, W A Bemelman, J D W van der Bilt, A D’Hoore, and P J Tanis, “Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review,” British Journal of Cancer, 2014.
- Paul H. Sugarbaker, “Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer,” World Journal of Gastroenterology, vol. 20, no. 28, pp. 9286–9291, 2014.
- A. Macri, F. Fleres, E. Cucinotta, and E. Saladino, “Reply to: Initial experience with hyperthermic intraperitoneal chemotherapy and cytoreductive surgery,” Indian Journal Of Cancer, vol. 51, no. 4, pp. 437–437, 2014.
- Dario Baratti, Shigeki Kusamura, and Marcello Deraco, “Prevention and early treatment of peritoneal metastases from colorectal cancer: Second-look laparotomy or prophylactic HIPEC?,” Journal of Surgical Oncology, 2014.
- Yeqian Huang, Nayef A. Alzahrani, Terence C. Chua, Winston Liauw, and David L. Morris, “Impacts of low peritoneal cancer index on the survival outcomes of patient with peritoneal carcinomatosis of colorectal origin,” International Journal of Surgery, 2015.
- Charlotte E L Klaver, Gijsbert D Musters, Willem A Bemelman, Cornelis J A Punt, Victor J Verwaal, Marcel GW Dijkgraaf, Arend GJ Aalbers, Jarmila DW van der Bilt, Djamila Boerma, Andre JA Bremers, Jacobus WA Burger, Christianne J Buskens, Pauline Evers, Robert J van Ginkel, Wilhelmina MU van Grevenstein, Patrick HJ Hemmer, Ignace HJT de Hingh, Laureen A Lammers, Barbara L van Leeuwen, Wilhelmus JHJ Meijerink, Simon W Nienhuijs, Jolien Pon, Sandra A Radema, Bert van Ramshorst, Petur Snaebjornsson, Jurriaan B Tuynman, Elisabeth A te Velde, Marinus J Wiezer, Johannes HW de Wilt, and Pieter J Tanis, “Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial,” BMC Cancer, vol. 15, no. 1, 2015.
- Karthik Chandra Vallam, AshwinDesouza, Munita Bal, PrachiPatil, Reena Engineer, and Avanish Saklani, “Adenocarcinoma of Rectum – a Composite of Three Different Subtypes with Varying Outcomes?,” Clinical Colorectal Cancer, 2015.
- Malin Enblad, Helgi Birgisson, Alkwin Wanders, Filip Sköldberg, Lana Ghanipour, and Wilhelm Graf, “Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy,” Annals of Surgical Oncology, 2015.
- Maurizio Cardi, Paolo Sammartino, Valentina Mingarelli, Simone Sibio, Fabio Accarpio, Daniele Biacchi, Daniela Musio, Bianca Sollazzo, and Angelo Di Giorgio, “Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis,” World Journal of Surgical Oncology, vol. 13, no. 1, 2015.
- James Oyeniyi, Jumin Wu, Diane Liu, James C. Yao, Holly Green, Karen Albritton, Winston Huh, and Andrea Hayes-Jordan, “Adolescents and Young Adults (AYA) with Colon Rectal Carcinoma(CRC) Including Treatment of Carcinomatosis Using Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC),” The American Journal of Surgery, 2015.
- Yeqian Huang, Nayef A. Alzahrani, Terence C. Chua, Winston Liauw, and David L. Morris, “Impacts of Peritoneal Cancer Index on The Survival Outcomes of Patients With Colorectal Peritoneal Carcinomatosis,” International Journal of Surgery, 2016.
- Allison Maciver, Nara Lee, Joseph J. Skitzki, Patrick Boland, and Valerie Francescutti, “Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms,” European Journal of Surgical Oncology (EJSO), 2016.
- Paolo Sammartino, Daniele Biacchi, Tommaso Cornali, Maurizio Cardi, Fabio Accarpio, Alessio Impagnatiello, Bianca Maria Sollazzo, and Angelo Di Giorgio, “Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC),” Indian Journal of Surgical Oncology, 2016.
- Dario Baratti, Shigeki Kusamura, Filippo Pietrantonio, Marcello Guaglio, Monica Niger, and Marcello Deraco, “Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review,” Critical Reviews in Oncology/Hematology, 2016.
- Dario Baratti, Shigeki Kusamura, and Marcello Deraco, “Colorectal Cancer Peritoneal Metastases,” Annals of Surgery, vol. 263, no. 1, pp. e5, 2016.